In Vitro Sensitivity of Cutaneous Leishmania Promastigote Isolates Circulating in French Guiana to a Set of Drugs. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue American Journal of Tropical Medicine and Hygiene Année : 2017

In Vitro Sensitivity of Cutaneous Leishmania Promastigote Isolates Circulating in French Guiana to a Set of Drugs.

Résumé

Anti-leishmaniasis drug resistance is a common problem worldwide. The aim of this study was to inventory the general in vitro level of sensitivity of Leishmania isolates circulating in French Guiana and to highlight potential in vitro pentamidine-resistant isolates. This sensitivity study was conducted on 36 patient-promastigote isolates for seven drugs (amphotericin B, azithromycin, fluconazole, meglumine antimoniate, miltefosine, paromomycin, and pentamidine) using the Cell Counting Kit-8 viability test. The IC50 values obtained were heterogeneous. One isolate exhibited high IC50 values for almost all drugs tested. Pentamidine, which is the first-line treatment in French Guiana, showed efficacy at very low doses (mean of 0.0038 μg/mL). The concordance of the in vitro pentamidine results with the patients' clinical outcomes was 94% (K = 0.82).
Fichier principal
Vignette du fichier
2017, Ginouves - In vitro sensitivity of cutaneous leishmania.pdf (331.35 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

inserm-01481512 , version 1 (02-03-2017)

Identifiants

Citer

Marine Ginouvès, Stéphane Simon, Mathieu Nacher, Magalie Pierre Demar, Bernard Carme, et al.. In Vitro Sensitivity of Cutaneous Leishmania Promastigote Isolates Circulating in French Guiana to a Set of Drugs.. American Journal of Tropical Medicine and Hygiene, 2017, [Epub ahead of print]. ⟨10.4269/ajtmh.16-0373⟩. ⟨inserm-01481512⟩
213 Consultations
304 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More